Recent Company News

• 05:20 AM ET Oct 30, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (86 total)

• 05:03 AM ET Oct 29, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (85 total)

• 05:27 PM ET Oct 28, 2026
  

  New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)

• 02:12 AM ET Oct 28, 2026
  

  DKSH acquires antibiotic brand Rocephin From Roche (CHF 77.00, 0.00)

• 02:05 AM ET Oct 28, 2026
  

  Roche Holding announced the global launch of the VENTANA BAP1 test (CHF 399.00, 0.00)

• 02:00 AM ET Oct 28, 2026
  

  Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

• 02:00 AM ET Oct 27, 2026
  

  Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

• 01:12 PM ET Oct 26, 2026
  

  Billions in New Plants, Trillions in Potential Obesity-Drug Revenue Over Two Decades

• 12:51 PM ET Oct 26, 2026
  

  FDA approves Talzenna for metastatic hormone-sensitive prostate cancer ($29.82, -0.22)

• 06:15 AM ET Oct 26, 2026
  

  StreetAccount Macro Headlines: